Proactive Investors - Run By Investors For Investors

Pressure BioSciences CEO sees increased revenue on projects and services in 2018

Pressure BioSciences (OTCMKTS:PBIO) CEO Richard Schumacher tells Proactive Investors the life science group reported a jump in first-quarter revenue thanks to an uptick in instrument sales, and said the company has shrunk its debt.

Schumacher says the company is very proud of their progress, having done $2.2mln in sales in 2017. He says the company has hired more sales staff, and touted a new pressure chamber instrument that allows for a number of "bells and whistles" for researchers

 
View full PBIO profile View Profile

Pressure BioSciences Inc Timeline

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use